- Home
- AGRO vs XERS Comparison
AGRO vs XERS Comparison
Compare AGRO & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGRO | XERS |
|---|---|---|
| Founded | 2002 | 2005 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | 2011 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AGRO | XERS |
|---|---|---|
| Price | $9.51 | $10.88 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $13.40 | $12.86 |
| AVG Volume (30 Days) | 507.4K | ★ 2.5M |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.69% | N/A |
| EPS Growth | N/A | ★ 100.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $49,590,000.00 |
| Revenue This Year | $56.84 | $32.91 |
| Revenue Next Year | N/A | $23.75 |
| P/E Ratio | $37.52 | ★ N/A |
| Revenue Growth | N/A | ★ 142.67 |
| 52 Week Low | $6.89 | $5.25 |
| 52 Week High | $15.89 | $11.42 |
Technical Indicators
Market Signals| Indicator | AGRO | XERS |
|---|---|---|
| Relative Strength Index (RSI) | 35.04 | 64.83 |
| Support Level | $8.72 | $5.90 |
| Resistance Level | $9.94 | N/A |
| Average True Range (ATR) | 0.37 | 0.51 |
| MACD | -0.08 | 0.04 |
| Stochastic Oscillator | 13.55 | 75.60 |
Price Performance
Historical ComparisonAbout AGRO Adecoagro S.A.
Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The group operates in two lines of business, namely, Farming and Sugar, Ethanol and Energy. The Farming is further comprised of three reportable segments: Crops, Rice and Dairy. Sugar, Ethanol and Energy Segment, consists of cultivating sugarcane, which is processed in owned sugar mills, transformed into ethanol, sugar and electricity, in addition to biomethane and then marketed.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.